Procyclidine
| Clinical data | |
|---|---|
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a605037 |
| Routes of administration | By mouth, im, iv |
| ATC code | |
| Pharmacokinetic data | |
| Protein binding | ~100%-albumin |
| Elimination half-life | ~12 h |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.931 |
| Chemical and physical data | |
| Formula | C19H30ClNO |
| Molar mass | 323.90 g·mol−1 |
| (verify) | |
Procyclidine is an anticholinergic drug principally used for the treatment of drug-induced parkinsonism, akathisia and acute dystonia, Parkinson's disease, and idiopathic or secondary dystonia.